ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors
Go back to ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors| Immucell Corp (NASDAQ: ICCC) | Delayed: 9.72 +0.23 (2.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.49 | 52 Week High | $8.29 | |||
| Open | $9.75 | 52 Week Low | $4.99 | |||
| Day High | $9.85 | P/E | 121.50 | |||
| Day Low | $9.65 | EPS | $0.08 | |||
| Volume | 13,877 | |||||
